TABLE 1.
Protein | Source species | Methoda | Sitesb | Variants | Exchange effects assayed | Citation |
---|---|---|---|---|---|---|
LacI | Escherichia coli | Sup | 328 (360) | 4038 | Operon repression, in vivo |
Markiewicz et al. (1994) |
Lysozyme | Phage T4 | Sup | 155 (164) | 1918 | Plaque size, in vivo | Rennell et al. (1991) |
Interleukin-3 | Homo sapiens | Sat | 103 (152) | 754 | Cell proliferation, in vivo |
Olins et al. (1995) |
Barnase | E. coli | Sat | 109 (110) | 676 | RNAse activity, in vivo | Axe et al. (1998) |
β-Lactamase | Pseudomonas | Sat | 27 (246) | 513 | Ampicillin resistance, in vivo |
Materon and Palzkill (2001) |
RecA | E. coli | Sat | 20 (323) | 380 | Plaque size, in vivo | Hortnagel et al. (1999) |
Reverse transcriptase | HIV | Sat | 109 (300) | 366 | RNA-dependent DNA polymerase activity, in vivo |
Wrobel et al. (1998) |
Protease | HIV | Sat | 99 (99) | 336 | Protease activity, in vivo |
Loeb et al. (1989) |
Protein V | Phage f1 | Sat | 86 (87) | 313 | Host inhibition, in vivo |
Zabin et al. (1991) |
Nuclease | Staphylococcus | Scan | 143 (149) | 290 | ΔΔG, in vitro | Green et al. (1992); Meeker et al. (1996); Shortle et al. (1990) |
Growth hormone | H. sapiens | Scan | 50 (191) | 50 | Dissociation constant, in vitro |
Cunningham and Wells (1989) |
Insulin | H. sapiens | Scan | 37 (51) | 37 | Receptor affinity, in vitro |
Kristensen et al. (1997) |
Total | 1266 | 9671 |
Sup, nonsense suppression; sat, saturation mutagenesis; scan, alanine scanning (Ala and Gly scanning in the case of Nuclease).
Amino acid positions altered (in parentheses, total number of positions in the protein).